FT Options LLC - CELLDEX THERAPEUTICS INC NEW ownership

Back to all holdings Add to watchlist

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 1 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
FT Options LLC ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2017$9,000
-66.7%
33,700
-30.8%
0.01%
-61.3%
Q4 2016$27,000
+35.0%
48,700
+94.8%
0.03%
+93.8%
Q3 2016$20,000
+122.2%
25,000
+85.2%
0.02%
+100.0%
Q2 2016$9,000–13,500–0.01%–
 Download
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q3 2023
NameSharesValueWeighting ↓
Byrne Asset Management LLC 86$2,0000.00%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders